Longboard Pharmaceuticals Inc (LBPH) Stock Analyst Earnings Estimates
NASDAQ:LBPH - Nasdaq - US54300N1037 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 3,203.35% | N/A 299.40% | N/A 94.41% | N/A 41.12% | N/A 89.00% | |||||
| EBITDA YoY % growth | N/A | -27.84M | -44.79M -60.88% | -56.754M -26.71% | N/A -69.66% | N/A -35.91% | N/A -20.65% | N/A 60.14% | N/A 169.21% | N/A 396.72% | N/A | N/A | |
| EBIT YoY % growth | -14.4M | -27.84M -93.33% | -44.8M -60.92% | -56.759M -26.69% | N/A -75.49% | N/A -31.79% | N/A -19.69% | N/A 12.75% | N/A 90.92% | N/A 1,273.61% | N/A 80.67% | N/A 87.89% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -2.15 | -2.57 -19.53% | -2.38 7.39% | N/A 4.61% | N/A -26.89% | N/A -11.47% | N/A -8.21% | N/A 41.78% | N/A 93.78% | N/A 1,789.62% | N/A 278.73% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.64 -3.17% | -0.70 -65.63% | -0.72 -28.96% | -0.72 -14.30% | -0.74 -15.44% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -26.826M -72.32% | -20.263M -11.90% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -28.412M -82.44% | -31.722M -75.16% | -33.316M -29.92% | -34.655M -23.22% | -37.243M -31.08% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.63 -14.55% | -0.59 | -0.04 | -6.75% |
| Q2 2024 Q2Q % growth | -0.56 13.85% | -0.45 | -0.11 | -24.62% |
| Q1 2024 Q2Q % growth | -0.42 25.00% | -0.50 | 0.08 | 15.33% |
| Q4 2023 Q2Q % growth | -0.62 6.06% | -0.61 | -0.01 | -1.77% |
| Q3 2023 Q2Q % growth | -0.55 19.12% | -0.72 | 0.17 | 23.41% |
| Q2 2023 Q2Q % growth | -0.65 2.99% | -0.61 | -0.04 | -6.97% |
| Q1 2023 Q2Q % growth | -0.56 | -0.59 | 0.03 | 4.40% |
| Q4 2022 Q2Q % growth | -0.66 -26.92% | -0.71 | 0.05 | 6.82% |
| Q3 2022 Q2Q % growth | -0.68 -78.95% | -0.65 | -0.03 | -4.79% |
| Q2 2022 Q2Q % growth | -0.67 -63.41% | -0.58 | -0.09 | -14.68% |
| Q1 2022 Q2Q % growth | -0.56 33.33% | -0.56 | 0.00 | 0.68% |
| Q4 2021 Q2Q % growth | -0.52 | -0.44 | -0.08 | -18.15% |
| Q3 2021 Q2Q % growth | -0.38 | -0.49 | 0.11 | 21.68% |
| Q2 2021 Q2Q % growth | -0.41 | -0.69 | 0.28 | 40.33% |
| Q1 2021 Q2Q % growth | -0.84 | -0.96 | 0.12 | 12.39% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.15% | -24.01% | -1.17% | -7.89% |
| Revenue | N/A | N/A | N/A | N/A |